Pulmonary Delivery of Theranostic Nanoclusters for Lung Cancer Ferroptosis with Enhanced Chemodynamic/Radiation Synergistic Therapy

• Published in: Nano letters Vol. 22; no. 3; pp. 963 - 972
• Main Authors: Li, Yingbo, Yang, Jie, Gu, Guangying, Guo, Xu, He, Chunbo, Sun, Jiemei, Zou, Hongyan, Wang, Hongbin, Liu, Shuang, Li, Xiaona, Zhang, Shujun, Wang, Kai, Yang, Lili, Jiang, Ying, Wu, Lina, Sun, Xilin
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 09.02.2022
• Subjects: Cell Line, Tumor; Ferroptosis; Humans; Hydrogen Peroxide - pharmacology; Lung Neoplasms - diagnostic imaging; Lung Neoplasms - drug therapy; Nanoparticles - therapeutic use; Neoplasms - drug therapy; Precision Medicine; Tumor Microenvironment; Ferroptosis; Lipid peroxide; Chemodynamic therapy; Radiotherapy; Lung cancer
• ISSN: 1530-6984; 1530-6992
• DOI: 10.1021/acs.nanolett.1c03786

Inefficient tumor accumulation and penetration remain as the main challenges to therapy efficacy of lung cancer. Local delivery of smart nanoclusters can increase drug penetration and provide superior antitumor effects than systemic routes. Here, we report self-assembled pH-sensitive superparamagnetic iron oxide nanoclusters (SPIONCs) that enhance in situ ferroptosis and apoptosis with radiotherapy and chemodynamic therapy. After pulmonary delivery in orthotopic lung cancer, SPIONCs disintegrate into smaller nanoparticles and release more iron ions in an acidic microenvironment. Under single-dose X-ray irradiation, endogenous superoxide dismutase converts superoxide radicals produced by mitochondria to hydrogen peroxide, which in turn generates hydroxyl radicals by the Fenton reaction from iron ions accumulated inside the tumor. Finally, irradiation and iron ions enhance tumor lipid peroxidation and induce cell apoptosis and ferroptosis. Thus, rationally designed pulmonary delivered nanoclusters provide a promising strategy for noninvasive imaging of lung cancer and synergistic therapy.